Oncternal Therapeutics, Inc. reports

Company location: San Diego, CA
Fiscal year end: 31 December

Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 501-525 of 1,000 matching filings.

Per page

25

Current page

21

8-K File 000-50549

8-K

Filing date: 12 Jun 2017
Reporting date: 12 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 15 May 2017
Reporting date: 12 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 15 May 2017
Reporting date: 12 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 15 May 2017
Reporting date: 12 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 15 May 2017
Reporting date: 12 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-50549

10-Q

Filing date: 15 May 2017
Reporting date: 31 Mar 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 15 May 2017
Reporting date: 15 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 11 May 2017
Reporting date: 11 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 03 May 2017
Reporting date: 03 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 05 Apr 2017
Reporting date: 03 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 05 Apr 2017
Reporting date: 03 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 05 Apr 2017
Reporting date: 03 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-50549

DEF 14A

Filing date: 31 Mar 2017
Reporting date: 11 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-50549

10-K

Filing date: 24 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 15 Mar 2017
Reporting date: 15 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Mar 2017
Reporting date: 28 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Mar 2017
Reporting date: 28 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Mar 2017
Reporting date: 28 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Mar 2017
Reporting date: 28 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Mar 2017
Reporting date: 28 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 28 Feb 2017
Reporting date: 28 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

FORM 3/A -

Filing date: 28 Feb 2017
Reporting date: 13 Jul 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-79588

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Filing date: 14 Feb 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-79588

FORMANEK INVESTMENT TRUST SC 13GA NO 3 10-14-2016 (GTX, INC)

Filing date: 02 Feb 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 09 Jan 2017
Reporting date: 06 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .